BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 19039025)

  • 41. B-type natriuretic peptide: a strong predictor of early and late mortality in patients with acute chest pain without ST-segment elevation in the emergency department.
    Bassan R; Tura BR; Maisel AS
    Coron Artery Dis; 2009 Mar; 20(2):143-9. PubMed ID: 19293713
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Within-person variation of the plasma concentration of B-type natriuretic peptide: safety range in stable patients with heart failure.
    Takeda Y; Takeda Y; Suzuki S; Kimura G
    Am Heart J; 2009 Jan; 157(1):97-101. PubMed ID: 19081403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Decrease of plasma N-terminal pro beta-type natriuretic peptide as a predictor of clinical improvement after cardiac resynchronization therapy for heart failure.
    Ding LG; Hua W; Zhang S; Chu JM; Chen KP; Wang Y; Wang FZ; Chen X
    Chin Med J (Engl); 2009 Mar; 122(6):617-21. PubMed ID: 19323922
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [N-terminal fragment of the brain natriuretic peptide and proinflammatory cytokines in patients with ischemic heart disease].
    Shalaev SV; Volkova SIu
    Ter Arkh; 2009; 81(5):30-6. PubMed ID: 19537583
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased circulating endothelins are not of cardiopulmonary origin in heart failure patients.
    Wang YZ; Goetze JP; Videbaek R; Rehfeld JF; Kastrup J
    Scand J Clin Lab Invest; 2005; 65(4):341-7. PubMed ID: 16076689
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Training-induced increase in nitric oxide metabolites in chronic heart failure and coronary artery disease: an extra benefit of water-based exercises?
    Laurent M; Daline T; Malika B; Fawzi O; Philippe V; Benoit D; Catherine M; Jacques R
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):215-21. PubMed ID: 19276981
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The additive value of N-terminal pro-B-type natriuretic peptide testing at the emergency department in patients with acute dyspnoea.
    van der Burg-de Graauw N; Cobbaert CM; Middelhoff CJ; Bantje TA; van Guldener C
    Eur J Intern Med; 2009 May; 20(3):301-6. PubMed ID: 19393498
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aminoterminal brain-type natriuretic peptide levels correlate with heart failure in patients with bidirectional Glenn anastomosis and with morbidity after the Fontan operation.
    Lechner E; Schreier-Lechner EM; Hofer A; Gitter R; Mair R; Biebl A; Tulzer G
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):560-4. PubMed ID: 19698835
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Could B-type Natriuretic Peptide (BNP) plasma concentration be useful to predict fluid responsiveness [corrected] in critically ill patients with acute circulatory failure?
    Muller L; Louart G; Teboul JL; Mahamat A; Polge A; Bertinchant JP; Ripart J; de La Coussaye JE; Lefrant JY
    Ann Fr Anesth Reanim; 2009 Jun; 28(6):531-6. PubMed ID: 19524395
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of systemic hypertension on the diagnostic performance of B-type natriuretic peptide in patients with acute dyspnea.
    Pahle AS; Sørli D; Omland T; Knudsen CW; Westheim A; Wu AH; Steg PG; McCord J; Nowak RM; Hollander JE; Storrow AB; Abraham WT; McCullough PA; Maisel A
    Am J Cardiol; 2009 Oct; 104(7):966-71. PubMed ID: 19766765
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transpulmonary B-type natriuretic peptide uptake and cyclic guanosine monophosphate release in heart failure and pulmonary hypertension: the effects of sildenafil.
    Melenovsky V; Al-Hiti H; Kazdova L; Jabor A; Syrovatka P; Malek I; Kettner J; Kautzner J
    J Am Coll Cardiol; 2009 Aug; 54(7):595-600. PubMed ID: 19660688
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Investigation of the possibility of using ischemia-modified albumin as a novel and early prognostic marker in cardiac arrest patients after cardiopulmonary resuscitation.
    Turedi S; Gunduz A; Mentese A; Dasdibi B; Karahan SC; Sahin A; Tuten G; Kopuz M; Alver A
    Resuscitation; 2009 Sep; 80(9):994-9. PubMed ID: 19581040
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The predictive value of plasma brain natriuretic peptide for the recurrence of atrial fibrillation six months after external cardioversion.
    Ari H; Binici S; Ari S; Akkaya M; Koca V; Bozat T; Gürdoğan M
    Turk Kardiyol Dern Ars; 2008 Oct; 36(7):456-60. PubMed ID: 19155659
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Osteopontin, a new prognostic biomarker in patients with chronic heart failure.
    Rosenberg M; Zugck C; Nelles M; Juenger C; Frank D; Remppis A; Giannitsis E; Katus HA; Frey N
    Circ Heart Fail; 2008 May; 1(1):43-9. PubMed ID: 19808269
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brain natriuretic peptide is removed by continuous veno-venous hemofiltration in pediatric patients.
    Ricci Z; Garisto C; Morelli S; Di Chiara L; Ronco C; Picardo S
    Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):33-6. PubMed ID: 19339274
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The use of B-type natriuretic peptide in paediatric patients: a review of literature.
    Favilli S; Frenos S; Lasagni D; Frenos F; Pollini I; Bernini G; Aricò M; Bini RM
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):298-302. PubMed ID: 19430339
    [TBL] [Abstract][Full Text] [Related]  

  • 57. B-type natriuretic peptide-guided management and outcome in patients with obesity and dyspnea--results from the BASEL study.
    Noveanu M; Breidthardt T; Cayir S; Potocki M; Laule K; Mueller C
    Am Heart J; 2009 Sep; 158(3):488-95. PubMed ID: 19699875
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure.
    Tsukamoto O; Fujita M; Kato M; Yamazaki S; Asano Y; Ogai A; Okazaki H; Asai M; Nagamachi Y; Maeda N; Shintani Y; Minamino T; Asakura M; Kishimoto I; Funahashi T; Tomoike H; Kitakaze M
    J Am Coll Cardiol; 2009 Jun; 53(22):2070-7. PubMed ID: 19477358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of deep vein thrombosis on ischaemia-modified albumin levels.
    Mentese A; Mentese U; Turedi S; Gunduz A; Karahan SC; Topbas M; Turan A; Patan T; Turkmen S; Okur G; Eminagaoglu MS
    Emerg Med J; 2008 Dec; 25(12):811-4. PubMed ID: 19033496
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum ischaemia-modified albumin increases in critical lower limb ischaemia.
    Gunduz A; Mentese A; Turedi S; Karahan SC; Mentese U; Eroglu O; Turkmen S; Turan I; Ucar U; Russell R; Balaban F
    Emerg Med J; 2008 Jun; 25(6):351-3. PubMed ID: 18499817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.